Codexis is a biotech company trying to turn cellulosic biomass into fuel. It was spun off from Maxygen in 2010.


Updates from The Motley Fool

Latest updates on Codexis from Fool.com.
3 Top Stocks Under $5

Looking to pick up a lot of shares of promising businesses? Take a closer look at BioAmber, Codex...



Stock Performance

View Interactive CDXS Charts
Sponsored by

Key Data Points

Primary metrics and data points about Codexis .
Current Price: $4.55
Prev Close: $4.60
Open: $4.55
Bid: $4.10
Ask: $4.80
Day's Range: $4.45 - $4.60
52wk Range: $3.54 - $5.28
Volume: 31,496
Avg Vol 141,150
Market Cap: $219M
P/E (ttm): -20.91
EPS (ttm): ($0.22)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Codexis .
CAPS Rating 2 out of 5
 
44 Outperform
7 Underperform
CAPS All Stars
 
7 Outperform
4 Underperform

How do you think Codexis will perform against the market?



You pick for Codexis is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

John J. Nicols, CEO

48% Approve

Based on 19 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Codexis .

Codexis is a biotech company trying to turn cellulosic biomass into fuel. It was spun off from Maxygen in 2010.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers